4//SEC Filing
Ticho Barry 4
Accession 0001780088-25-000004
CIK 0001623526other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:20 PM ET
Size
10.5 KB
Accession
0001780088-25-000004
Insider Transaction Report
Form 4
Ticho Barry
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2025-11-03$25.22/sh−3,776$95,247→ 9,350 total - Sale
Common Stock
2025-11-03$27.54/sh−600$16,524→ 7,295 total - Sale
Common Stock
2025-11-03$29.35/sh−100$2,935→ 7,195 total - Sale
Common Stock
2025-11-03$26.02/sh−1,455$37,860→ 7,895 total
Footnotes (4)
- [F1]The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.74 to $25.65 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 4.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.79 to $26.50 per share, inclusive.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.40 to $27.60 per share, inclusive.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001780088
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 4:20 PM ET
- Size
- 10.5 KB